Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Peptides Help with Stretch Marks: Formulation Comparison

Palmitoyl Pentapeptide-4 (Matrixyl) Mimics procollagen fragment, upregulates collagen I/III gene expression via TGF-β receptor binding 20.4% width reduction in RCT (Dermatologic Surgery 2015), 64% responder rate at 12 weeks Mature white stretch marks (striae a

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Palmitoyl Pentapeptide-4 (Matrixyl)
  • Mimics procollagen fragment, upregulates collagen I/III gene expression via TGF-β receptor binding
  • 20.4% width reduction in RCT (Dermatologic Surgery 2015), 64% responder rate at 12 weeks
  • Mature white stretch marks (striae albae) needing texture improvement
  • Requires liposomal delivery or hyaluronic acid carrier
  • Most evidence-backed for established scars. Consistent but modest results
  • Copper Tripeptide-1 (GHK-Cu)
  • Activates metalloproteinases to degrade damaged collagen, stimulates new collagen and GAG synthesis
  • 15.7% pigmentation improvement, 12.3% elasticity gain (J Drugs Dermatol 2018)
  • Pigmentation contrast reduction in white stretch marks
  • Penetrates well at 3% concentration without additional carriers
  • Best for pigmentation mismatch. Less effective for deep textural scarring
  • Acetyl Hexapeptide-8 (Argireline)
  • Reduces dermal micro-contractions, allows uniform collagen deposition, secondary anti-inflammatory effect
  • 19% improvement in striae rubrae over 8 weeks (Clin Cosmet Investig Dermatol 2020)
  • Fresh red stretch marks (striae rubrae) with active inflammation
  • Effective at 5% with standard cream base
  • Most effective on fresh marks. Minimal effect on mature white scars
  • Hexapeptide-11
  • Stimulates collagen IV and laminin-5 synthesis in dermal-epidermal junction
  • Limited published data. Primarily in vitro fibroblast studies
  • Theoretical benefit for early intervention
  • Unknown penetration profile
  • Insufficient clinical evidence for standalone recommendation